Get the Stockscreener App
4.32
5.05%
-0.23
Clover Health Investments Corp stock is traded at $4.32, with a volume of 2.90M.
It is down -5.05% in the last 24 hours and down -17.08% over the past month.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
See More
Previous Close:
$4.55
Open:
$4.6
24h Volume:
2.90M
Relative Volume:
0.39
Market Cap:
$2.28B
Revenue:
$2.21B
Net Income/Loss:
$-56.94M
P/E Ratio:
-38.43
EPS:
-0.1124
Net Cash Flow:
$54.54M
1W Performance:
-6.49%
1M Performance:
-17.08%
6M Performance:
+66.80%
1Y Performance:
+40.49%
1-Day Range:
$4.32
$4.60
1-Week Range:
$4.32
$4.878
52-Week Range:
$1.58
$5.59
Clover Health Investments Corp Stock (CLOV) Company Profile
Name
Clover Health Investments Corp
Sector
Industry
Phone
(201) 432-2133
Address
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
4.32 | 2.28B | 2.21B | -56.94M | 54.54M | -0.1124 |
UNH
Unitedhealth Group Inc
|
420.74 | 382.09B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
107.74 | 137.47B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
377.68 | 81.91B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
289.57 | 76.60B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
389.32 | 46.74B | 137.20B | 1.15B | 1.27B | 9.3439 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Craig Hallum | Buy |
| Oct-07-24 | Initiated | UBS | Neutral |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Feb-02-22 | Upgrade | Cowen | Underperform → Market Perform |
| Jan-19-22 | Initiated | SVB Leerink | Mkt Perform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Jan-07-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-10-21 | Initiated | Cowen | Underperform |
| Sep-02-21 | Resumed | Citigroup | Neutral |
| Jul-12-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| May-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Feb-02-21 | Initiated | Citigroup | Buy |
| Feb-01-21 | Initiated | JP Morgan | Neutral |
View All
Clover Health Investments Corp Stock (CLOV) Latest News
Clover Health Investments Corp (CLOV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Clover Health Investments Corp. Class A Revenue Breakdown – MUN:7QD - TradingView
ETFs Investing in Clover Health Investments Corp. Class A Stocks - TradingView
Clover Health Investments Corp. Class A Revenue Breakdown – LS:A2QJXX - TradingView
Clover Health Data Breach Lawsuit Investigation - Claim Depot
Clover Health Investments, Corp. (CLOV) Options Chain - Yahoo! Finance Canada
CLOV|Clover Health Investments Corp|Price:4.320|Chg%:-0.230 - TradingKey
Clover Health Investments (CLOV) Citi Annual Global Healthcare Conference 2025 summary - Quartr
Clover Health Interim CFO to Present at Aug. 11 Conference - Stock Titan
Clover Health stock trades steadily as Medicare Advantage focus meets mixed financials - AD HOC NEWS
CLOV Maintained by Canaccord Genuity -- Price Target Raised to $5.50 - GuruFocus
Clover Health Chief Legal Officer Karen Soares disposes of 51,700 common shares for $233,167 - Bitget
Insider Sell: Karen Soares Sells 51,700 Shares of Clover Health Investments Corp (CLOV) - GuruFocus
Clover Health CLOV: Chief Legal Officer Karen Soares Executes Planned Sale of 51,700 Shares - Kalkine Media
Clover Health (CLOV) insider files to sell 51,700 shares of common stock - Stock Titan
Insider Sell: Jamie Reynoso Sells Shares of Clover Health Investments Corp (CLOV) - GuruFocus
Clover Health Investments Corp (CLOV) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Clover Health CEO, Medicare Advantage Jamie L. Reynoso disposes of 4,839 shares for $21,920.67 - Bitget
Form 4 Clover Health Investments Corp For: 17 July By Investing.com - Investing.com Nigeria
Abbott investigates two separate cyber incidents, says no operations affected - Reuters
Clover Health Investments (CLOV) insider sells 4,839 shares under 10b5-1 - Stock Titan
Clover Health CEO Jamie Reynoso sells $21,920 in CLOV stock - Investing.com
Clover Health CEO Jamie Reynoso sells $21,920 in CLOV stock By Investing.com - Investing.com Nigeria
Clover Health Investments Corp Reports Anomalous Login Activity On Information Systems On July 4, 2026SEC Filing - TradingView
Clover Health Reports Cybersecurity Incident, Enhances Protections - TipRanks
Clover Health says employee accounts accessed in cyber incident - Reuters
Form 144 Clover Health Investments For: 17 July By Investing.com - Investing.com India
Executive (NASDAQ: CLOV) schedules Rule 144 share sale and details past trades - Stock Titan
Clover Health (NASDAQ: CLOV) details cyber incident affecting 3 employee accounts - Stock Titan
Clover Health CEO Jamie Reynoso sells $61,265 in stock By Investing.com - Investing.com South Africa
Clover Health chief legal officer sells $49,123 in stock By Investing.com - Investing.com South Africa
Clover Health CEO Andrew Toy sells $292,860 in shares By Investing.com - Investing.com Nigeria
Form 4 Clover Health Investments Corp For: 16 July By Investing.com - Investing.com Nigeria
Clover Health: Counterpart Health CEO Wai sells $113,084 in stock. By Investing.com - Investing.com Nigeria
Clover Health chief legal officer sells $49,123 in stock - Investing.com
Clover Health CEO Andrew Toy sells $292,860 in shares - Investing.com
Clover Health: Counterpart Health CEO Wai sells $113,084 in stock. - Investing.com
Clover Health (CLOV) CEO sells 62,711 shares for RSU tax withholding - Stock Titan
Clover Health (NASDAQ: CLOV) insider sale covers RSU tax obligations - Stock Titan
Clover Health (CLOV) exec sells 13,119 shares to cover RSU tax withholding - Stock Titan
Clover Health Investments (CLOV) legal chief sells shares in tax-cover transaction - Stock Titan
Clover Health (CLOV) interim CFO sells 4,630 shares to cover taxes - Stock Titan
Broadwind Leads The Charge With 2 Other Promising Penny Stocks - simplywall.st
Form 144 Clover Health Investments For: 15 July By Investing.com - Investing.com Nigeria
Issuer (NASDAQ: CLOV) plans 10,192-share Class A sale under 10b5-1 plan - Stock Titan
Sale of 12,712 shares planned in CLOV (Nasdaq: CLOV) notice - Stock Titan
CLOV (Nasdaq: CLOV) plans Rule 144 sale of 60765 shares - Stock Titan
CLOV (CLOV) plans sale of 23,463 Class A common shares - Stock Titan
Clover Health Investments (CLOV) Faces A Valuation Test Ahead Of August Earnings - Yahoo Finance
CLOVER HEALTH SHAREHOLDER NOTICE - TMX Newsfile
Clover Health Investments Corp Stock (CLOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.85%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):